(USD) | Mar 2024 | Q/Q |
---|---|---|
Revenue | 88.4B | -6% |
Gross Profit | 40.4B | - |
Cost Of Revenue | 48.1B | -16% |
Operating Income | 2.3B | -33% |
Operating Expenses | - | - |
Net Income | 1.1B | -46% |
Amortization | 508MM | -0% |
Interest Expense | 716MM | +4% |
Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
The latest trading day saw CVS Health (CVS) settling at $58.65, representing a +0.19% change from its previous close.
The DTC brand’s nonprescription products debuted on the drugstore’s website and will be in stores by August.
Insurers with a focus on Medicaid are seeing higher costs per member after millions of enrollees were forced out of the plans.
Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” second quarter 2024 investor letter. A copy of the letter can be downloaded here. During the quarter, the strategy returned -1.9% net of fees compared to the S&P 500’s 4.3% return. According to a three-factor performance attribution model, allocation and interaction effects […]
Zacks.com users have recently been watching CVS Health (CVS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Top executives of CVS Caremark, Optum Rx and Express Scripts made a rare congressional appearance to defend pharmacy benefit managers’ drug pricing policies.
Findings from the House Oversight investigation add to criticism that pharmacy-benefit managers are driving up drug spending.
Investing in solid dividend-paying stocks can be a reliable strategy for long-term wealth building. By choosing stocks with strong fundamentals and growth potential, investors can ride out market fluctuations and achieve significant returns. Here, we ...
CVS Caremark®, the nation's leading pharmacy benefit manager and a CVS Health® (NYSE: CVS) company, today announced a renewed pledge to American businesses, unions, and health plans — building on what the company is doing to deliver greater transparency, lower drug costs, and better clinical care for the most utilized health benefit.